{"best_oa_location":null,"data_standard":2,"doi":"10.7164/antibiotics.46.1082","doi_url":"https://doi.org/10.7164/antibiotics.46.1082","first_oa_location":null,"genre":"journal-article","has_repository_copy":false,"is_oa":false,"is_paratext":false,"journal_is_in_doaj":false,"journal_is_oa":false,"journal_issn_l":"0021-8820","journal_issns":"0021-8820,1881-1469","journal_name":"The Journal of Antibiotics","oa_locations":[],"oa_locations_embargoed":[],"oa_status":"closed","published_date":"1993-01-01","publisher":"Japan Antibiotics Research Association","title":"Eupenifeldin, a novel cytotoxic bistropolone from Eupenicillium brefeldianum.","updated":"2025-08-27T01:23:51Z","year":1993,"z_authors":[{"author_position":"first","is_corresponding":true,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"FRIEDRICH MAYERL"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"QI GAO"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"STELLA HUANG"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"STEVEN E. KLOHR"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"JAMES A. MATSON"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"DONALD R. GUSTAVSON"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"DOLORES M. PIRNIK"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"RONALD L. BERRY"},{"author_position":"additional","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"CRAIG FAIRCHILD"},{"author_position":"last","is_corresponding":false,"raw_affiliation_strings":["Pharmaceutical Research Institute, Bristol-Myers Squibb Company"],"raw_author_name":"WILLIAM C. ROSE"}]}